What Is the Prognosis for COVID-19 Treatments and Vaccines?


2020 Global Conference

What Is the Prognosis for COVID-19 Treatments and Vaccines?



October 12 at 7:45 am PDT/10:45 am EDT


Individuals across the US have adapted to a largely isolated lifestyle due to COVID-19, and many do not expect to return to normalcy until a COVID-19 vaccine is developed. Even with a vaccine, challenges and questions, such as vaccine access and public trust, will remain top of mind. While efforts in vaccine development surge forward, research on treatments for the symptoms of COVID-19 holds promise for preventing disease and extending life for patients with COVID-19. Experts at the forefront of research and development will discuss current standings and projections for COVID-19 vaccines and therapies, and will address some of the most pressing questions around the future of R&D for COVID-19.

This session will incorporate live polling, presented by the Harris Poll. This interactive feature is available for registered participants only.


Meg Tirrell

Biotech and Pharma Reporter, CNBC



Michelle McMurry-Heath

President and CEO, Biotechnology Innovation Organization

Mark Suzman

CEO, Bill & Melinda Gates Foundation

Janet Woodcock

Senior Advisor, Food and Drug Administration


Published October 12, 2020